iCell Cardiomyocytes

What's New

Milwaukee Journal-Sentinel:
Cellular Dynamics International Awarded National Eye Institute Contract

See the article...

Science & Technology

Episomla Reprogramming

About Us

With 100+ employees and >800 patents, CDI manufactures human iPS cell-derived cell types with the quality, quantity, and purity required for basic life science and drug discovery research.
Read more...

iCell® Products

iCell Cardiomyocytes

more...
iCell Cardiomyocytes
close

iCell Cardiomyocytes are specifically designed to aid drug discovery and improve the predictability of drug efficacy and toxicity screens, weeding out ineffective and potentially toxic compounds.

iCell Cardiac
Progenitor Cells

more...
iCell Cardiac Progenitor Cells
close

iCell Cardiac Progenitor Cells provide a relevant substrate for traditional small molecule/biologic discovery screens, as well as a platform to develop methods whereby progenitor cells can be used as a regenerative medicine therapeutic.

iCell Neurons

more...
iCell Neurons
close

iCell Neurons are derived from human induced pluripotent stem (iPS) cells and provide a unique in vitro system for preclinical drug discovery, neurotoxicity testing, predictive disease modeling, and basic cellular research.

iCell DopaNeurons

more...
iCell DopaNeurons
close

iCell DopaNeurons, a highly pure population of human floor plate-derived midbrain dopaminergic neurons, are an ideal in vitro model to investigate native neural biology and neurodegenerative diseases.

iCell Astrocytes

more...
iCell Astrocytes
close

iCell Astrocytes provide a reliable source of high quality, high purity human astrocytes and are ideal for in vitro astrocyte-mediated neurotoxicity, targeted drug discovery, blood brain barrier modeling, and other life science research.

iCell Hepatocytes

more...
iCell Hepatocytes
close

iCell Hepatocytes provide access to commercial quantities of high quality, high purity human liver cells for preclinical drug discovery, hepatotoxicity testing, and disease research.

iCell Skeletal
Myoblasts

more...
iCell Skeletal Myoblasts
close

iCell Skeletal Myoblasts cells can be used to understand and modulate basic cellular developmental processes, implemented into targeted and phenotypic screens for molecular therapies, and be deployed as a platform to develop cellular therapies for regenerative medicine.

iCell Endothelial
Cells

more...
iCell Endothelial Cells
close

iCell Endothelial Cells are designed for use in vascular-targeted drug discovery, tissue regeneration, and other life science research.

iCell Macrophages

more...
iCell Macrophages
close

iCell Macrophages can be applied in variety of applications including co-culture in tumor models, immune response, inflammation, toxicity testing, and infectious disease modeling.

iCell Hematopoietic Progenitor Cells

more...
iCell Hematopoietic
Progenitor Cells
close

Derived from human iPS cells, iCell Hematopoietic Progenitor Cells are human multipotent hematopoietic progenitor cells that can be further differentiated into diverse terminal cell types within the hematopoietic lineage.


MyCell® Products

MyCell Products


iCell Community

Join the scientists switching to human iPSC-derived cells to advance research in toxicity, discovery, and regenerative medicine. See their stories:


Customer Stories